# Approval Disparities for New Drugs in the US and Japan

## TL;DR

This study compares how new drugs are approved in the US and Japan over 18 years.

## Contribution

It identifies disparities in drug approval rates and timelines between the two countries.

## Key findings

- The US approved drugs faster than Japan during the study period.
- Certain therapeutic areas showed larger approval gaps between the two countries.
- Regulatory differences may contribute to these disparities.

## Abstract

This cross-sectional study evaluates drug approval disparities between the US and Japan from 2005 to 2022.